On Target Laboratories, Inc.

About On Target Laboratories, Inc.

On Target Laboratories is dedicated to developing targeted intraoperative molecular imaging agents to illuminate cancerous tissue during surgery, aiding surgeons in detecting and removing more cancer in real-time, with a mission to completely remove cancer and improve patient outcomes.

Products & Services

Cytalux:An FDA-approved intraoperative molecular imaging agent designed to detect tumors during surgery by lighting the way to identify cancerous tissue.

Specialties

Intraoperative Molecular Imaging Cancer Detection Technology Real-Time Cancer Imaging

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2023-11-16 FD: 2023-11-16	7 investors

Series C Latest

2023-11-16

$30.0M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Philip Low

Chief Science Officer

B

Bill Peters

President, Chief Executive Officer, and Board Member

R

Rod MacLeod

Chief Financial Officer

S

Shane Johnson

Executive Vice President Sales

T

Tim Biro

Vice President of Product Development

C

Catherine Brisson

Vice President of Regulatory Affairs and Quality

View 13 more team members with Pro

Unlock Full Team Directory

Recent News